STEPHAN DIETRICH A (President and CEO) received a stock award from NEUBASE THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/17/2023ACC: 0001104659-23-033856
DirectorOfficer· President and CEO
Since Jul 2019
+153K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
153K acquired
Non-Derivative Transactions1
Common stock
Direct
Shares
+153K
Price / share
—
Trade value
—
% of position
New position
3/16/2023
0.00→153K
Total
Net shares
+153K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock Direct | 3/16/2023 | A · Award | +153K | — | — | New position | 0.00 | 153K |
| Total | +153K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common stock
DirectShares owned1.47M
Common stock
IndirectShares owned1.27M
Total
1.47M direct·1.27M indirect2.75M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common stock | 1.47M | Direct |
| Common stock | 1.27M | Indirect |
| Total | 2.75M | 1.47M direct·1.27M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported